[Use of muramyl peptides in viral vaccines].
Discusses the selective activation of HIV replication under the effect of various muramylpeptides with immunostimulating effect. Emphasizes the significance of selecting adjuvants inducing no HIV activation, particularly in cases when the vaccines are intended for seropositive subjects.
Krivorutchenko
Iu L
IuL
D016915:AIDS Vaccines / Q000737:chemistry* / Q000494:pharmacology; D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000494:pharmacology*; D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology; D006801:Humans; D014775:Virus Activation; D014779:Virus Replication / Q000187:drug effects
D016915:AIDS Vaccines; D000276:Adjuvants, Immunologic; D000119:Acetylmuramyl-Alanyl-Isoglutamine